The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics

M.J. Jardine, K.W. Mahaffey, B. Neal, R. Agarwal, G.L. Bakris, B.M. Brenner, S. Bull, C.P. Cannon, D.M. Charytan, D. De Zeeuw, R. Edwards, T. Greene, H.J.L. Heerspink, A. Levin, C. Pollock, D.C. Wheeler, J. Xie, H. Zhang, B. Zinman, M. DesaiV. Perkovic

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)462-472
Number of pages11
JournalAmerican Journal of Nephrology
Issue number6
Publication statusPublished - 2018
Externally publishedYes

Cite this